Efficacy Seen When Daratumumab is Added to Treatment in Multiple Myeloma
In an interview with Targeted OncologyTM Nina Shah, MD, discusses the findings from several trials that show the efficacy of daratumumab for patients with multiple myeloma.
Ide-Cel CAR T-Cell Therapy Demonstrates Promise in Heavily Pretreated Myeloma
Nina Shah, MD, discusses the potential role of idecabtagene vicleucel as treatment of patients with multiple myeloma.
Shah Discusses Hope for CAR T-Cell Therapy in Multiple Myeloma
Nina Shah, MD, discusses the question of whether CAR T-cell therapy is ready for primetime in patients with multiple myeloma.